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Egg and peanut allergies are among the most common childhood 
food allergies. The estimated prevalence of egg allergy is 0.5 - 8.9% in 
early childhood,[1-6] while peanut allergy prevalence has a wide range 
according to geographical area, generally ~0.5 - 2.0%, but as high as 
5.9% in some countries such as Sweden.[7-9] Figures are higher, ~15 - 
30% for egg allergy and 10 - 25% for peanut allergy, in children with 
moderate to severe atopic dermatitis (AD).[10-12] 
The natural history of egg and peanut allergy varies significantly. 
Egg allergy has a good overall prognosis, with half of children 
becoming tolerant by 3 years, 66% by 5 years[13] and ~80% by adoles-
cence. The prognosis may be more guarded in those attending a 
specialised allergy clinic. A retrospective chart review of 881 children 
with egg allergy in a North American tertiary referral centre showed a 
slower development of tolerance – 4% by 4 years, 12% by 6 years, 37% 
by 10 years and 68% by 16 years.[14] In a tertiary centre in Japan, 60% 
of children with hen’s egg allergy at age 6 years were found to outgrow 
the allergy by age 12 years; the prognosis was more guarded in those 
with a past history of an anaphylactic reaction, in whom 44% outgrew 
the allergy by the age of 12 years.[15] 
Clinical and laboratory factors that affect the development of 
tolerance to egg include milder symptoms on egg ingestion, skin test 
and egg IgE size at diagnosis, rate of change of IgE levels and presence 
of multiple food allergies.[16-18] Gal d 1 (ovomucoid) is the dominant 
allergen in egg white. Studies addressing persistence of egg allergy 
found higher concentrations of IgE anti-ovomucoid antibodies in 
persons with persistent allergy than in those who outgrew their egg 
allergy.[19] 
Peanut allergy is persistent in the majority of cases, and only 
outgrown in ~20% of patients.[20-23] A low peanut-specific IgE (sIgE) 
at initial diagnosis may predict tolerance acquisition. A North 
American study of 84 patients with peanut allergy showed that those 
with a peanut IgE level <5 kU/L at diagnosis had a 50% chance of 
outgrowing their allergy.[24] Those who had an anaphylactic reaction 
to peanut were less likely to outgrow their allergy.[22]
A further North American study that followed up 223 patients with 
peanut allergy showed that 21.5% outgrew their allergy.[25] Peanut sIgE 
was not different at diagnosis, but significantly lower in the tolerance 
group at the time of rechallenge (median 0.69 kU/L in those who 
developed tolerance v. 2.06 kU/L in those with persistent allergy). 
Because of the persistent nature of peanut allergy, education 
regarding peanut avoidance and treatment of adverse reactions is 
necessary in all cases of clinical peanut hypersensitivity. Nonetheless, 
the rate of accidental ingestion is high. In a follow-up study of 83 children 
with peanut allergy, 58% had experienced adverse reactions from 
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Background. There are no previous data on tolerance development in children with atopic dermatitis (AD) and concomitant food allergy 
in low- and middle-income settings. 
Objectives. To determine the rate of tolerance acquisition to egg and peanut 5 years after diagnosing food allergies in South African (SA) 
children with AD, and to explore factors influencing tolerance acquisition. 
Methods. Five years after first diagnosing food allergy in 37 SA children with egg and/or peanut allergy, they were reassessed for their 
allergies by questionnaire, skin-prick tests (SPTs) and ImmunoCAP-specific IgE (sIgE) tests (Thermo Fisher Scientific/Phadia, Sweden) to 
egg white, ovomucoid, peanut and Arachis hypogaea allergen 2 (Ara h 2), and incremental food challenges. 
Results. Eighteen of 25 originally egg-allergic patients and 19 of 24 originally peanut-allergic children were followed up at a median age 
of 8 years and 3 months and 9 years and 6 months, respectively. A high percentage of children (72.2%) outgrew their egg allergy, and 
15.8% outgrew their peanut allergy. Allergic comorbidity remained high, with asthma increasing over time, and AD remaining moderate 
in severity in the cohort overall. At diagnosis, sIgE egg white ≤9.0 kU/L and sIgE ovomucoid ≤2.0 kU/L were associated with tolerance 
development to egg 5 years later. At follow-up, sIgE egg white ≤0.70 kU/L, sIgE ovomucoid ≤0.16 kU/L, SPT egg-white extract ≤1 mm and 
SPT fresh egg ≤5 mm were associated with tolerance. At diagnosis, sIgE Ara h 2 ≤1.7 kU/L and SPT peanut ≤10 mm were associated with 
tolerance development to peanut 5 years later. At follow-up, sIgE peanut ≤0.22 kU/L, sIgE Ara h 2 ≤0.18 kU/L and SPT peanut ≤5.5 mm 
were associated with tolerance. 
Conclusions. Egg allergy was outgrown in 72.2% and peanut allergy in 15.8% of SA children 5 years after diagnosis of AD. This is in keeping 
with findings derived from studies in higher socioeconomic settings, and can help to guide the counselling of patients with allergies to these 
foods of high nutritional value. 
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accidental peanut exposure after 5 years, and half of those had 
experienced potentially life-threatening reactions, regardless of the 
nature of their initial reaction.[22] 
Data on food allergy in low- and middle-income countries are 
sparse. In a South African (SA) study of food allergy prevalence in 
children with moderate to severe AD, 25% had egg allergy and 24% 
pea nut allergy.[12] In this cohort, commonly used positive predictive 
cut-off values in skin-prick tests (SPTs) to egg white and peanut were 
poorly predictive for true allergy, leading the authors to propose that 
higher cut-off values should be used in such settings. 
There are no data on factors influencing tolerance development in 
children with AD and concomitant food allergy in low- and middle-
income settings. Many common food allergens are nutritious and 
affordable, and alternatives are expensive and not always readily 
available; hence, knowledge of the natural history of common food 
allergies is of particular importance in this setting. 
This study aimed to determine the rate of acquisition of egg and 
peanut allergy tolerance in SA children with AD and concomitant 
food allergy. A secondary objective was to explore factors, at 
diagnosis and follow-up, which affect tolerance acquisition.
Methods
Children (6 months - 10 years of age) with moderate (SCORing 
Atopic Dermatitis (SCORAD) 15 - 40) to severe (SCORAD >40) 
AD and concommitant food allergy were followed up 5 years after 
diagnosis. Participants had previously been assessed for food allergies 
by detailed history, SPTs and ImmunoCAP tests (Thermo Fisher 
Scientific/Phadia, Sweden) for allergen sIgE and incremental open 
food challenges.[12,26,27] Children with a prior diagnosis of egg and/or 
peanut allergy were reassessed by detailed questionnaire, SPTs and 
ImmunoCAP tests. SPTs were performed to egg white extract and 
peanut extract (ALK Abelló, Spain), as well as fresh raw egg white. 
SPT results were recorded as mean wheal diameter (largest diameter 
and perpendicular) minus mean wheal diameter of the negative 
control. All participants underwent ImmunoCAP tests to egg white, 
ovomucoid, peanut and Arachis hypogaea  allergen 2 (Ara h 2). All 
patients also underwent an incremental open food challenge to egg 
and/or peanut, depending on their original allergy.
For egg, the challenge food was given in the form of scrambled egg, 
starting with a lip challenge, followed by incremental increases every 
15 - 20 minutes, from 0.5 g to 30 g scrambled egg (~50 mg - 3 g egg-
white protein), over 2 hours. 
For peanut, the challenge food was given in the form of peanut 
butter, starting with a lip challenge, followed by increases from 0.1 g 
to 17 g of peanut butter (~25 mg - 4 g peanut protein) over 2 hours, 
with dose increments every 15 - 20 minutes. 
Ethical approval
This study was approved by the University of Cape Town’s Human 
Research Ethics Committee (ref. no. 224/2015).
Statistical analysis
Data distribution was asymmetrical. The χ2 test and the Wilcoxon 
rank sum test were used to determine statistical significance (p<0.05). 
Medians and interquartile ranges were used for descriptive statistics. 
Results
Egg allergy
Follow-up rates and acquisition of tolerance
Eighteen of 25 participants previously diagnosed with egg allergy 
completed a full follow-up, including food challenges (72.0% follow-
up rate). The other 7 were lost to follow-up. There were no significant 
differences in baseline characteristics between those followed up 
and those lost to follow-up, including original eczema severity by 
SCORAD, age at study entry, asthma prevalence, SPT size to egg and 
raw egg, sIgE to egg white and ovomucoid at diagnosis, and severity 
of previous reactions (Table E1*).
The median age of those followed up and undergoing challenge was 
8 years and 3 months (99 (interquartile range (IQR) 82 - 116) months). 
None of the patients followed up had experienced a severe reaction 
to egg (anaphylaxis) at the time of study entry. Nine of 18 patients 
(50.0%) had accidentally ingested whole egg during the 5 years since 
the initial study, of whom 5 had reacted at the time of accidental 
ingestion, none with an anaphylactic reaction. 
Overall, 13/18 participants (72.2%) passed their egg challenge 
and were classified as having outgrown their egg allergy. Nine of 10 
(90.0%) of those of mixed ethnicity outgrew their allergies at a median 
age of 82 (IQR 76 - 118) months and 4/8 (50.0%) of the black Africans 
outgrew their egg allergy at a median age of 105 (IQR 99 - 113) months 
(inter-ethnic difference in outgrowing egg allergy, p=0.06). 
Allergic comorbidity
Eleven of 18 participants (61.0%) had asthma at reassessment com-
pared with 7/18 (38.9%) with asthma at the time of the original study; 
hence, there was a 22.0% increase in asthma over 5 years in this group. 
At the time of diagnosis, 3/13 (23.1%) of those who later outgrew their 
egg allergy had asthma, and 4/5 (80.0%) of those with persistent egg 
allergy had asthma (p=0.027). At follow-up, the difference in asthma 
rates was no longer statistically significant: of those who outgrew 
their egg allergy, 7/13 had asthma (53.8%), and of those who did not 
outgrow their egg allergy, 4/5 had asthma (80.0%; p=0.33). 
The median SCORAD at study entry in the group who outgrew 
their egg allergy was 48 (IQR 44 - 52) compared with 35 (IQR 34 - 48) 
in those who did not outgrow their egg allergy (p=0.255). At follow-
up, the median SCORAD in those who outgrew their egg allergy (26; 
IQR 15 - 30) and those who did not (30; IQR 29 - 44) had decreased 
over the course of the 5 years. 
Specific IgE tests to egg white and ovomucoid at diagnosis and 
follow-up in relation to tolerance acquisition
The sIgE to egg white and ovomucoid at diagnosis and follow-up 
is compared in those who outgrew their egg allergy and those with 
persistent allergy (Table 1). 
Skin-prick tests to egg-white extract and fresh egg at diagnosis 
and follow-up in relation to tolerance acquisition 
SPTs to egg-white extract and fresh raw egg white at diagnosis and 
follow-up are compared in those who outgrew their allergy with 
those with persistent allergy (Table 1).
Ratios of follow-up results to original results
The ratios of median sIgE egg at follow-up and diagnosis are depicted 
in Table 1; similar ratios for ovomucoid sIgE, SPT to egg-white 
extract and SPT to fresh raw egg white are depicted in Table 1. 
Peanut allergy
Follow-up rates and acquisition of tolerance
Nineteen of 24 participants previously diagnosed with peanut and 
egg allergy completed a full follow-up, including a peanut butter 
food challenge (79.2% follow-up rate). There were no significant 
differences in baseline characteristics between those followed up 
and those lost to follow-up with regard to age at study entry, asthma 
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prevalence, SPT size to peanut, sIgE to peanut and Ara h 2 at diagnosis 
and severity of original reaction. SCORAD at the time of diagnosis 
was significantly higher in those lost to follow-up (Table E2*).
The median age of those followed up and challenged was 9 years 
and 6 months (114 (IQR 77 - 148) months). Six of 19 patients (31.6%) 
had accidentally ingested peanut during the 5 years since the initial 
study, of whom 4 had reacted at the time of accidental ingestion, 1  with 
an anaphylactic reaction. 
Three of 19 children (15.8%) acquired tolerance at a median age of 
8 years and 4 months (100 (IQR 68 - 157) months); 1/13 (7.7%) child -
ren of mixed race outgrew their allergies at the age of 68 months; 
and 2/6 (33.3%) of black Africans outgrew their peanut allergy at a 
median age of 128.5 (IQR 100 - 157) months (inter-ethnic difference 
in outgrowing peanut allergy, p=0.16). 
Four of 19 patients followed up for peanut allergy had severe 
anaphylactic symptoms originally. Of 3 patients who outgrew their 
peanut allergy, none had severe symptoms originally, whereas 4/16 
(25%) of those who did not outgrow their peanut allergy had 
previously experienced severe symptoms (p=0.33).
Allergic comorbidity 
Nine of 19 participants (47.4%) had asthma at reassessment compared 
with 8/19 (42.1%) with asthma at the time of the original study; 
hence, there was a 5% increase in asthma over 5 years in this group. 
At diagnosis, of those who subsequently outgrew their peanut 
allergy, 1/3 (33.3%) had asthma, whereas 7/16 (43.8%) of those 
with persistent peanut allergy had asthma (p=0.74). At the time of 
the follow-up study, of those who outgrew their peanut allergy, 2/3 
(66.7%) had asthma, and of those who did not outgrow their peanut 
allergy, 7/16 (43.8%) had asthma (p=0.46). 
The median SCORAD at study entry in the group that subsequently 
outgrew their peanut allergy was 31 (IQR 22 - 46) compared with 41.5 
(IQR 32 - 52) in those who did not outgrow their peanut allergy (p=0.22). 
In the follow-up study, the median SCORAD in those who outgrew their 
peanut allergy (26.5, IQR 19 - 31) and in those who did not (26, IQR 20 
- 45) (p=0.72) had decreased, but was in the moderate range. 
Specific IgE tests to peanut and Ara h 2 at diagnosis and follow-up 
in relation to tolerance acquisition
The sIgE to peanut and Ara h 2 at diagnosis and follow-up are 
compared in patients who outgrew their peanut allergy and in those 
with persistent allergy (Table 2). 
Skin-prick tests to peanut at diagnosis and follow-up in relation 
to tolerance acquisition 
SPTs to peanut at diagnosis and follow-up are compared in those 
who outgrew their allergy and those with persistent allergy (Table 2). 
Ratios of follow-up results to original results
The ratios of median sIgE peanut at follow-up compared with those 
at diagnosis are depicted in Table 2; ratios for Ara h 2 sIgE and SPTs 
to peanut at follow-up v. at diagnosis are also depicted in Table 2. 
Discussion
This is the first SA study assessing factors influencing tolerance 
development in children with AD and concomitant food allergy in 
low- and middle-income settings. Egg and peanut allergies were 
predominant in the cohort, with large enough numbers for follow-up 
5 years after the diagnosis of food allergy. 
Seventy-two percent of children with egg allergy outgrew their 
allergy 5 years after diagnosis at a median age of 8 years and 4 months. 
This is similar to tolerance acquisition rates in other countries,[13] but 
higher than that in several studies from tertiary centres.[14,15] The rate 
of tolerance acquisition for egg did not differ according to ethnicity. 
Table 1. Factors affecting tolerance acquisition in egg allergy
Factor
Children who 
acquired tolerance 
to egg 
Children with 
persistent egg allergy Difference (p-value) 
Asthma at diagnosis, % 23.1 80.0 0.027
Asthma at follow-up, % 53.8 80.0 0.33
Median SCORAD at diagnosis (IQR) 48 (44 - 52) 35 (34 - 48) 0.255
Median SCORAD at follow-up (IQR) 26 (15 - 30) 30 (29 - 44) 0.17
sIgE egg white at diagnosis, kU/L (IQR) 9.2 (6.2 - 40.0) 100 (100 - 100)* 0.002
sIgE egg white at follow-up, kU/L (IQR) 0.7 (0.3 - 2.0) 20.7 (8.6 - 49.9) 0.007
sIgE ovomucoid at diagnosis, kU/L (IQR) 2.0 (0.3 - 6.3) 100.0 (63.2 - 100.0)* 0.001
sIgE ovomucoid at follow-up, kU/L (IQR) 0.2 (0.1 - 0.4) 23.3 (4.3 - 66.4) 0.006
SPT egg-white extract at diagnosis, mm (IQR) 6 (5 - 6) 6 (1 - 7) 0.840
SPT egg-white extract at follow-up, mm (IQR) 1 (0 - 5) 7.5 (5 - 8) 0.002
SPT fresh raw egg white at diagnosis, mm (IQR) 14 (12 - 20) 13 (12 - 15) 0.80
SPT fresh raw egg white at follow-up, mm (IQR) 5 (2 - 9) 12 (10 - 13) 0.048
Median ratio
sIgE egg white at follow-up/diagnosis, % (IQR) 16.0 (16.6 - 38.0) 20.7 (8.6 - 50.0) 0.533
Median ratio
sIgE ovomucoid at follow-up/diagnosis, % (IQR) 20.0 (2.0 - 45.0) 23.3 (6.7 - 66.0) 0.61
Median ratio
SPT egg white at follow-up/diagnosis, % (IQR) 14.0 (0 - 116.0) 112.0 (83.0 - 150.0) 0.075
Median ratio
SPT raw egg at follow-up/diagnosis, % (IQR) 42.0 (0 - 74) 94.0 (80 - 100) 0.012
SCORAD = SCORing Atopic Dermatitis; IQR = interquartile range; sIgE = specific IgE; SPT = skin-prick test.
*100 = the upper limit measured for egg and ovomucoid sIgE. 
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Asthma prevalence was high in participants with egg allergy and 
increased over the follow-up period, both in those who outgrew 
their allergy and in those with persistent allergy. This is in keeping 
with previous studies showing egg allergy as a significant risk factor 
for asthma development.[28] AD, although reducing somewhat in 
severity over time, remained of moderate severity in the majority of 
participants – in those who had acquired tolerance to egg and in those 
with persistent allergy. 
The median sIgE to both egg white and ovomucoid was significantly 
higher at diagnosis and follow-up in those with persistent egg allergy 
than in those who developed tolerance. At diagnosis, sIgE egg white 
and ovomucoid >100 kU/L were associated with persistent allergy 
after 5 years; and sIgE egg white ≤9.0 kU/L and ovomucoid ≤2.0 kU/L 
at diagnosis were associated with tolerance development. At follow-
up, sIgE egg white ≥20.0 kU/L and ovomucoid ≥23.0 kU/L were 
associated with persistent allergy, while sIgE egg white ≤0.70 kU/L 
and ovomucoid ≤0.16 kU/L were associated with tolerance. 
However, the trend in those who outgrew their egg allergy was a 
reduction in sIgE to egg and ovomucoid over time, suggesting that 
more children might outgrow their egg allergy. 
The size of the original SPT to both egg extract and raw egg did not 
significantly influence the chances of developing tolerance. However, 
the SPT area to egg extract and fresh raw egg white at follow-up was 
significantly larger in the group with persistent egg allergy. At follow-
up, an SPT to egg-white extract ≥7.5 mm and fresh egg ≥12 mm was 
associated with persistence, while an SPT to egg-white extract 
≤1 mm and raw egg ≤5 mm was associated with tolerance. The SPT 
to fresh raw egg was generally higher than that of the egg extract and 
in many cases remained positive (median 5 mm) even if the child 
had outgrown the egg allergy. Therefore, the clinician should strongly 
consider an egg challenge if the egg extract result becomes negative, 
even in the presence of a positive raw egg SPT. 
In this cohort, 15.8% of children outgrew their peanut allergy 
after 5 years. This is in keeping with previous studies showing 
acquisition of tolerance in ~20% of peanut-allergic children.[20-24] 
Asthma prevalence remained stable in those who retained and in 
those who outgrew their peanut allergy. Similar to the group with egg 
allergy, eczema severity reduced over time, but remained of moderate 
severity in the majority of participants. 
The median sIgE to peanut at diagnosis was not significantly 
higher in those who persisted in their allergy; however, it was sig-
nificantly higher for Ara h 2 in the persistence group. At diagnosis, 
sIgE to Ara h 2 ≥16.95 kU/L was associated with persistence, and 
to Ara h 2 ≤1.7 kU/L with tolerance development. At follow-up, 
sIgE to peanut ≥31.9 kU/L and Ara h 2 ≥18.6 kU/L was asso ciated 
with persis tent allergy, while sIgE to peanut ≤0.22 kU/L and Ara h 2 
≤0.18 kU/L was associated with tolerance. At diagnosis, an SPT ≥14 mm 
was associated with persistence and an SPT ≤10 mm with tolerance 
acquisition, while at follow-up, an SPT ≥12 mm was associated with 
persistence and an SPT ≤5.5 mm with tolerance acquisition. The 
ratio of the follow-up peanut IgE compared with the original IgE was 
significantly lower in the group who outgrew their peanut allergy, 
indicating a significant fall in IgE over time. 
In peanut allergy, neither ethnicity nor the number of allergies at 
diagnosis affected the development of tolerance. 
This study, in a low- and middle-income socioeconomic setting 
in an African country, mirrors the substantial differences in the 
natural history of egg and peanut allergy demonstrated in previous 
studies in higher socioeconomic settings, indicating that differences 
in the immunology of egg and peanut allergy seem ubiquitous 
across different geographical, socioeconomic and ethnic settings. A 
greater understanding of the reasons for such differences may help to 
provide an opportunity for clinical or immunological interventions 
in food allergy. Understanding the natural history of common food 
allergens in the SA setting allows for appropriate counselling of food-
allergic children, and provides guidance to the treating clinicians on 
avoidance and reintroduction of foods as nutritious, cost-effective 
and ubiquitous as egg and peanut in a resource-constrained setting.
Study strengths and limitations
Strengths of the study are that every patient underwent a food 
challenge irrespective of SPTs and sIgE levels. The small cohort size 
and 20 - 30% loss-to-follow-up rate may have affected the conclusions. 
Maximal effort was made to phone, email, send letters and do home 
Table 2. Factors affecting tolerance acquisition in peanut allergy
Factor
Children who 
acquired tolerance to 
peanut
Children with persistent 
peanut allergy 
Difference 
(p-value) 
Asthma at diagnosis, % 33.3 43.8 0.74
Asthma at follow-up, % 66.7 43.8 0.46
Median SCORAD at diagnosis (IQR) 31.0 (22 - 46) 41.5 (32 - 52) 0.22
Median SCORAD at follow-up (IQR) 26.5 (19 - 31) 26 (20 - 45) 0.72
sIgE peanut at diagnosis, kU/L (IQR) 12.7 (1.8 - 23.4) 17.2 (10.7 - 87.8) 0.31
sIgE peanut sIgE at follow-up, kU/L (IQR) 0.22 (0.1 - 0.3) 31.9 (8.9 - 56.9) 0.02
sIgE Ara h 2 at diagnosis, kU/L (IQR) 1.7 (0.84 - 2.63) 16.9 (7.9 - 33.6) 0.02
sIgE  Ara h 2 at follow-up, kU/L (IQR) 0.18 (0.10 - 0.26) 18.6 (4.63 - 24.90) 0.03 
SPT peanut at diagnosis, mm (IQR) 10 (4 - 11) 14 (11.5 - 18.5) 0.04
SPT peanut at follow-up, mm (IQR) 5.5 (5.0 - 8.0) 12.3 (9.2 - 13.2) 0.02
Median ratio
sIgE peanut at follow-up/diagnosis, % (IQR) 4.0 (3 - 5) 99.5 (57 - 162) 0.02
Median ratio
sIgE Ara h 2 at follow-up/diagnosis, % (IQR) 8.0 (6 - 10) 71.5 (39 - 137) 0.03
Median ratio
SPT peanut at follow-up/diagnosis, % (IQR) 73.0 (55 - 120) 75.0 (61 - 100) 0.86
SCORAD = SCORing Atopic Dermatitis; IQR = interquartile range; sIgE = specific IgE; Ara h 2 = Arachis hypogaea allergen 2; SPT = skin-prick test.
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visits to follow up patients, but the migrant nature of this population 
meant that many had moved to other areas of the country. 
Conclusions
In SA children with AD, egg allergy was outgrown in 72.2% and 
peanut allergy in 15.8% 5 years after diagnosis. This is in keeping 
with figures derived from studies in higher socioeconomic settings, 
and can help to guide counselling of patients with allergies to these 
foods of high nutritional value. Allergic comorbidity remained high, 
with asthma increasing over time and AD remaining moderate in 
severity in the cohort overall. Low sIgEs to peanut, Ara h 2, egg white 
and ovomucoid at diagnosis and follow-up may indicate possible 
development of tolerance and guide the appropriate timing of food 
challenges. SPTs at follow-up (egg and peanut) and at diagnosis 
(peanut allergy only) can also be used to help to prognosticate allergy 
persistence and guide the appropriate timing of challenges. 
*Tables E1 and E2 are available from the corresponding author on request.
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